SIRPA and neoplasm: Moreover, a combination of anti-SIRPα with IgA tumor targeting also promoted neutrophil recruitment to the tumor site in vivo [86], consistent with the known stimulating effects of IgA on neutrophil-recruiting chemoattractants, such as LTB4, which act in an autocrine fashion and may help to form a positive feedback loop [71].